These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 22984697)

  • 1. [III. Method and current problem of follow up and future possibility of clinical trials for lung cancer-based on practice guideline].
    Shiono S
    Gan To Kagaku Ryoho; 2012 Aug; 39(8):1201-4. PubMed ID: 22984697
    [No Abstract]   [Full Text] [Related]  

  • 2. [Revised by the Japan lung cancer society: guideline for diagnosis and treatment of lung cancer].
    Hayakawa K
    Gan To Kagaku Ryoho; 2011 Aug; 38(8):1273-6. PubMed ID: 21877333
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical Guidelines for the Management of Lung Cancer and evaluation from clinical practice].
    Morikawa T
    Nihon Geka Gakkai Zasshi; 2007 Sep; 108(5):237-41. PubMed ID: 17907451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2010 Consensus on Lung Cancer, new clinical recommendations and current status of biomarker assessment--first-line therapy.
    Gridelli C; Rossi A; Maione P
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S248-57. PubMed ID: 21943982
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical practice guideline for lung cancer].
    Hayakawa K; Tsuboi M
    Gan To Kagaku Ryoho; 2010 Apr; 37(4):609-12. PubMed ID: 20414015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of quality indicators for diagnosis and treatment of patients with non-small cell lung cancer: a first step toward implementing a multidisciplinary, evidence-based guideline.
    Hermens RP; Ouwens MM; Vonk-Okhuijsen SY; van der Wel Y; Tjan-Heijnen VC; van den Broek LD; Ho VK; Janssen-Heijnen ML; Groen HJ; Grol RP; Wollersheim HC
    Lung Cancer; 2006 Oct; 54(1):117-24. PubMed ID: 16920220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Practice guidelines for non-small cell lung cancer.
    Cameron R; Fringer J; Taylor C; Gilden CR; Figlin RA
    Cancer J Sci Am; 1996; 2(3A Suppl):S61-8. PubMed ID: 9166525
    [No Abstract]   [Full Text] [Related]  

  • 8. Utility of screening procedures for detecting recurrence of disease after complete response in patients with small cell lung carcinoma.
    Perez EA; Loprinzi CL; Sloan JA; Owens DT; Novotny PJ; Bonner JA
    Cancer; 1997 Aug; 80(4):676-80. PubMed ID: 9264350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of multidisciplinary lung cancer practice.
    Conron M; Phuah S; Steinfort D; Dabscheck E; Wright G; Hart D
    Intern Med J; 2007 Jan; 37(1):18-25. PubMed ID: 17199840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The ASCO experience with evidence-based clinical practice guidelines.
    Smith TJ; Somerfield MR
    Oncology (Williston Park); 1997 Nov; 11(11A):223-7. PubMed ID: 9430192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between clinical decisions made about lung cancer patients and those inherent in the corresponding Scottish Intercollegiate Guidelines Network (SIGN) guideline.
    Sleeman D; Moss L; Gyftodimos E; Nicolson M; Devereux G
    Health Informatics J; 2010 Dec; 16(4):260-73. PubMed ID: 21216806
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Update of the NCCN ovarian cancer practice guidelines.
    Ozols RF
    Oncology (Williston Park); 1997 Nov; 11(11A):95-105. PubMed ID: 9430180
    [No Abstract]   [Full Text] [Related]  

  • 13. Lung cancer guidelines: why do we need them?
    O'Connell F
    Ir Med J; 2004 Feb; 97(2):36-7. PubMed ID: 15134265
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunotherapy of lung cancer: an update.
    Rüttinger D; Winter H; van den Engel NK; Hatz RA; Schlemmer M; Pohla H; Grützner S; Schendel DJ; Fox BA; Jauch KW
    Onkologie; 2006 Feb; 29(1-2):33-8. PubMed ID: 16514254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Follow-up of patients with thoracic malignancies.
    Virgo KS; Johnson FE; Naunheim KS
    Surg Oncol Clin N Am; 1999 Apr; 8(2):355-69. PubMed ID: 10339651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reported management of lung cancer in Victoria in 1993: comparison with best practice. Anti-Cancer Council of Victoria Lung Cancer Study Group.
    Richardson GE; Thursfield VJ; Giles GG
    Med J Aust; 2000 Apr; 172(7):321-4. PubMed ID: 10844918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ACR Appropriateness Criteria: nonsurgical treatment for non-small-cell lung cancer: good performance status/definitive intent.
    Gewanter RM; Rosenzweig KE; Chang JY; Decker R; Dubey S; Kong FM; Lally BE; Langer CJ; Lee HK; Movsas B
    Curr Probl Cancer; 2010; 34(3):228-49. PubMed ID: 20541060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Promising lung cancer vaccine.
    Environ Health Perspect; 1996 Nov; 104(11):1147-8. PubMed ID: 8959399
    [No Abstract]   [Full Text] [Related]  

  • 19. Early detection for lung cancer. New tools for casefinding.
    Lam S; Lam B; Petty TL
    Can Fam Physician; 2001 Mar; 47():537-44. PubMed ID: 11281087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current vaccine updates for lung cancer.
    Simmons O; Magee M; Nemunaitis J
    Expert Rev Vaccines; 2010 Mar; 9(3):323-35. PubMed ID: 20218860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.